23 results on '"Ye, Yangliang"'
Search Results
2. Discovery of a novel GPR35 agonist with high and equipotent species potency for oral treatment of IBD
3. Phenotypic screening-based drug discovery of furan-2-carboxylic acid derivatives for the amelioration of type 2 diabetes mellitus (T2DM)
4. Design of G-protein-coupled bile acid receptor 1 (GPBAR1, TGR5) soft drugs with reduced gallbladder-filling effects
5. TGR5 agonist ameliorates insulin resistance in skeletal muscles and improves glucose homeostasis in diabetic mice
6. Design, synthesis and structure−activity relationship studies of GPR40 agonists containing amide linker
7. General Pharmacological Activation Mechanism of K+ Channels Bypassing Channel Gates
8. Discovery of novel ketoxime ether derivatives with potent FXR agonistic activity, oral effectiveness and high liver/blood ratio
9. General Pharmacological Activation Mechanism of K+ Channels Bypassing Channel Gates.
10. Pyrimidinyl-arylpropionic acid derivatives: viable resources in the development of new antineoplastic agents
11. Antitumor activity of a novel series of α-aryloxy-α-methylhydrocinnamic acid derivatives as PPAR gamma agonists against a panel of human cancer cell lines
12. TGR5 agonist ameliorates insulin resistance in the skeletal muscles and improves glucose homeostasis in diabetic mice.
13. Linderane Suppresses Hepatic Gluconeogenesis by Inhibiting the cAMP/PKA/CREB Pathway Through Indirect Activation of PDE 3 via ERK/STAT3
14. Discovery and Structure–Activity Relationship Study of 4-Phenoxythiazol-5-carboxamides as Highly Potent TGR5 Agonists
15. Discovery of Intestinal Targeted TGR5 Agonists for the Treatment of Type 2 Diabetes
16. Corrigendum: Design, Synthesis, and Structure-Activity Relationships of 3,4,5-Trisubstituted 4,5-Dihydro-1,2,4-oxadiazoles as TGR5 Agonists
17. Design, Synthesis, and Structure–Activity Relationships of 3,4,5‐Trisubstituted 4,5‐Dihydro‐1,2,4‐oxadiazoles as TGR5 Agonists
18. Pyrimidinyl-arylpropionic acid derivatives: viable resources in the development of new antineoplastic agents
19. Antitumor Efficacy of Two Novel Non-Thiazolidinedione Compounds as Peroxisome Proliferator-Activated Receptor-γ Agonists in Human Osteosarcoma Cells in vitro
20. Antitumor activity of a novel series of α-aryloxy-α-methylhydrocinnamic acid derivatives as PPAR gamma agonists against a panel of human cancer cell lines
21. General Pharmacological Activation Mechanism of K+Channels Bypassing Channel Gates
22. General Pharmacological Activation Mechanism of K + Channels Bypassing Channel Gates.
23. Antitumor efficacy of two novel non-thiazolidinedione compounds as peroxisome proliferator-activated receptor-gamma agonists in human osteosarcoma cells in vitro.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.